Related Experiment Video
Updated: Aug 6, 2026

Formulation of Zinc-Based Nanomaterials using the Eucommia ulmoides Bark Extract and their Wound Healing Potential
Published on: December 27, 2024
Green Ziziphus nummularia gold nanoparticles: antioxidant and anticancer activity in TNBC
Rola Abdallah1, Rami Abdel-Rahem2, Adnan Badran3
1Department of Biology, American University of Beirut, P.O. Box 110236, Beirut, Lebanon.
Abstract:
Triple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes with limited targeted therapeutic options, highlighting the need for innovative, biocompatible treatment strategies. Plant-mediated green synthesis offers a sustainable route for gold nanoparticle (AuNP) fabrication with enhanced biological functionality. In this study, Ziziphus nummularia ethanolic extract (ZNE) was employed as a reducing and capping agent to synthesize stable, crystalline, and predominantly spherical gold nanoparticles (ZNE-AuNPs). Comprehensive physicochemical characterization confirmed successful nanoparticle formation and phytochemical capping. Importantly, this work provides novel biological and mechanistic insights into the anticancer effects of ZNE-AuNPs specifically in TNBC. ZNE-AuNPs exhibited notable antioxidant activity and significantly reduced the viability of MDA-MB-231 TNBC cells in a concentration- and time-dependent manner. For the first time, the anticancer activity of ZNE-AuNPs in TNBC was mechanistically linked to the suppression of cellular proliferation (decreased Ki-67), induction of apoptosis (modulation of BAX, BCL-2, and caspase-3), and inhibition of ERK phosphorylation, implicating the MAPK/ERK signaling pathway. Taken together, these findings support Ziziphus nummularia-derived AuNPs as a sustainable nanotherapeutic platform and establish their previously unexplored mechanistic relevance in TNBC.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules
